J M Herrera, W A Alvarez, J P Freinhar, W B Lawson, J J Sramek
{"title":"辅助氯硝西泮治疗慢性精神分裂症。","authors":"J M Herrera, W A Alvarez, J P Freinhar, W B Lawson, J J Sramek","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Clonazepam was added to the neuroleptic regimen of 3 treatment-resistant schizophrenic patients with schizoaffective features. Manic symptoms improved but returned following discontinuation of clonazepam. The drug appears to benefit positive psychotic symptoms but worsens negative symptoms.</p>","PeriodicalId":77182,"journal":{"name":"International journal of psychosomatics : official publication of the International Psychosomatics Institute","volume":"38 1-4","pages":"17-20"},"PeriodicalIF":0.0000,"publicationDate":"1991-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Adjunctive clonazepam in the treatment of chronic schizophrenia.\",\"authors\":\"J M Herrera, W A Alvarez, J P Freinhar, W B Lawson, J J Sramek\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Clonazepam was added to the neuroleptic regimen of 3 treatment-resistant schizophrenic patients with schizoaffective features. Manic symptoms improved but returned following discontinuation of clonazepam. The drug appears to benefit positive psychotic symptoms but worsens negative symptoms.</p>\",\"PeriodicalId\":77182,\"journal\":{\"name\":\"International journal of psychosomatics : official publication of the International Psychosomatics Institute\",\"volume\":\"38 1-4\",\"pages\":\"17-20\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1991-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of psychosomatics : official publication of the International Psychosomatics Institute\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of psychosomatics : official publication of the International Psychosomatics Institute","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Adjunctive clonazepam in the treatment of chronic schizophrenia.
Clonazepam was added to the neuroleptic regimen of 3 treatment-resistant schizophrenic patients with schizoaffective features. Manic symptoms improved but returned following discontinuation of clonazepam. The drug appears to benefit positive psychotic symptoms but worsens negative symptoms.